Industry Jargon

Chemistry, Manufacturing, and Controls

(CMC)

Innovator Drug

The chemical composition of the drug, the manufacturing process, and the tests developed to ensure its effectiveness and consistency.

A new brand-name drug that is first made and marketed by a pharmaceutical company. Innovator drugs are usually protected by patents, which give the company that developed the drug exclusive rights to sell it for a certain period of time.

Pipeline Drugs

Drugs in the development stages, but not yet approved the FDA. The term can also be used to refer to drugs that are already approved by the FDA but are still in the process of being marketed and sold.

Key Opinion Leader (KOL)

A well-respected person with experience and expertise in a particular field. In healthcare, these leaders could be physicians, hospital directors, researchers, and people who make clinical guidelines.

Payer A payer is any entity that pays for the use of healthcare services or products delivered. The term usually refers to health insurance companies. Payers determine how patients get access to drugs through their insurance, and how providers get paid for their services.

Claims Data

In HEOR, claims data refers to information collected from insurance claims and other data sources. It includes information on patient demographics, diagnoses, treatments, and costs. It is often used evaluate the effectiveness and cost-effectiveness of healthcare decisions and policies.